These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis. Chen HW; Zhu JL; Martyanov V; Tsoi LC; Johnson ME; Barber G; Popovich D; O'Brien JC; Coias J; Cyrus N; Malviya N; Florez-Pollack S; Kunzler E; Hosler GA; Gudjonsson JE; Khanna D; Whitfield M; Jacobe HT J Invest Dermatol; 2023 Oct; 143(10):1886-1895.e10. PubMed ID: 37028702 [TBL] [Abstract][Full Text] [Related]
11. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Valenzi E; Bulik M; Tabib T; Morse C; Sembrat J; Trejo Bittar H; Rojas M; Lafyatis R Ann Rheum Dis; 2019 Oct; 78(10):1379-1387. PubMed ID: 31405848 [TBL] [Abstract][Full Text] [Related]
12. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin]. Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902 [TBL] [Abstract][Full Text] [Related]
13. Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Castello-Cros R; Whitaker-Menezes D; Molchansky A; Purkins G; Soslowsky LJ; Beason DP; Sotgia F; Iozzo RV; Lisanti MP Cell Cycle; 2011 Jul; 10(13):2140-50. PubMed ID: 21670602 [TBL] [Abstract][Full Text] [Related]
14. Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis. Soare A; Györfi HA; Matei AE; Dees C; Rauber S; Wohlfahrt T; Chen CW; Ludolph I; Horch RE; Bäuerle T; von Hörsten S; Mihai C; Distler O; Ramming A; Schett G; Distler JHW Arthritis Rheumatol; 2020 Jan; 72(1):137-149. PubMed ID: 31350829 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Sambo P; Baroni SS; Luchetti M; Paroncini P; Dusi S; Orlandini G; Gabrielli A Arthritis Rheum; 2001 Nov; 44(11):2653-64. PubMed ID: 11710721 [TBL] [Abstract][Full Text] [Related]
17. Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. Kirk TZ; Mark ME; Chua CC; Chua BH; Mayes MD J Biol Chem; 1995 Feb; 270(7):3423-8. PubMed ID: 7852429 [TBL] [Abstract][Full Text] [Related]
18. Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a trend towards normalisation over time. Skaug B; Lyons MA; Swindell WR; Salazar GA; Wu M; Tran TM; Charles J; Vershel CP; Mayes MD; Assassi S Ann Rheum Dis; 2022 Apr; 81(4):516-523. PubMed ID: 34937693 [TBL] [Abstract][Full Text] [Related]
19. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis. Li SC Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497 [TBL] [Abstract][Full Text] [Related]